Ellen Chiniara, Chief Legal Officer at Kymera Therapeutics, Inc. (KYMR), sold 6,258 shares at $41.75 ($261K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Open-market sale of $261k KYMR by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.75 | 3,129 | $131K | 50.0% |
| 2 | $41.75 | 3,129 | $131K | 50.0% |
| Total | $41.75 avg | 6,258 | $261K | 100% |
| Filing → |